Healthcare Equipment and Supplies
Company Overview of MC10, Inc.
MC10, Inc. manufactures stretchable electronic products. It offers BioStamp Research Connect system that gathers complex physiological data; WiSP, a cardiac monitoring and ECG recording solution; and BioStampMD, a wearable sensors conform to the human body to collect objective and patient-reported subjective data. The company sells products online. MC10, Inc. was founded in 2008 and is based in Lexington, Massachusetts.
10 Maguire Road
Lexington, MA 02421
Founded in 2008
Key Executives for MC10, Inc.
Chief Executive Officer, President and Executive Director
Co-Founder and Senior Vice President of Corporate Development
Co-Founder, Chief Technology Officer and Senior Vice President
Compensation as of Fiscal Year 2016.
MC10, Inc. Key Developments
MC10, Inc. Appoints Keith A. Katkin to Board of Directors
Nov 15 16
MC10, Inc. announced the appointment of Keith A. Katkin to the company’s Board of Directors. Mr. Katkin served as the president and Chief Executive Officer of Avanir Pharmaceuticals from 2007 through the company’s acquisition by Otsuka Pharmaceuticals in 2015. Mr. Katkin was appointed by the company’s Board of Directors to lead Avanir through turnaround and restructuring, and his successful implementation of a new corporate strategy increased market capitalization from $50 million to $3.5 billion and grew the team from 17 employees to over 500. Prior to serving as President and CEO, Mr. Katkin led all sales, marketing, and medical affairs at Avanir as the Senior Vice President of Sales and Marketing. Mr. Katkin was the Vice President of Commercial and Business Development at the privately owned Peninsula Pharmaceuticals from 2004 to 2005 and the Vice President of Marketing at Intermune, a publicly traded biotechnology company, from 2002 to 2004. He previously held several titles at Amgen and Abbott Laboratories. Mr. Katkin currently serves on the Board of Directors of Avanir Pharmaceuticals, Carbylan Therapeutics, Brain Injury Association of America, CoverMyMeds, Otic Pharmaceuticals, and Rigel Pharmaceuticals.
MC10 and PCH Enters into Exclusive Partnership to Commercialize MC10’s Wearable Interactive Stamp Platform
Apr 12 16
MC10, Inc. and PCH have entered into an exclusive partnership to commercialize MC10’s Wearable Interactive Stamp Platform (WiSP™). The partnership will allow brands to develop a variety of consumer applications for the platform, which is a skin-worn, ultra-thin, stretchable and disposable stamp. When paired with a smartphone, tablet, or near field communication (NFC) reader, the WiSP platform enables a variety of consumer applications, such as cashless payments, hotel room access, event registration, interactive experiences at amusement parks, sporting and music events and VIP experiences. The WiSP platform can also be used in clinical environments to transmit important patient information and streamline procedure flow. PCH will work with third-party brands to customize the technology and develop new consumer applications. The smart stamp was first commercialized in conjunction with L’Oréal as the stretchable electronic designed to measure individual UV exposure. L’Oréal will retain exclusivity for applications of this technology in the beauty domain. The stamp leverages NFC technology to enable a variety of interactions between brand and wearer. By combining cloud analytics with the WiSP platform, brands can deepen their understanding of consumer behavior. To maintain the security of the stored information, the breathable, waterproof stamp is designed to tear and become unreadable upon removal.
MC10 Names Eric K. Brandt to the Board of Directors
Apr 11 16
MC10 reported that Eric K. Brandt has been appointed to the company's Board of Directors. Brandt served as Executive Vice President and Chief Financial Officer of Broadcom Corp., a position he held between March 2007 and January 2016.
Similar Private Companies By Industry
Recent Private Companies Transactions
December 2, 2016